Skip to main content

Table 3 Treatment-related toxicity

From: Feasibility and efficacy of simultaneous integrated boost intensity-modulated radiation therapy in patients with limited-disease small cell lung cancer

 

Grade (n = 35) number (percent) of patients

Category

1

2

3

4

Hematologic toxicity (WBC)

4(11%)

21(60%)

9(26%)

1(3%)

Hematologic toxicity (PLT)

4(11%)

2(6%)

2(6%)

3(9%)

Hematologic toxicity (HB)

8(23%)

5(14%)

4(11%)

3(9%)

Stomach/intestine

13(37%)

11(31%)

2(6%)

0

Esophagitis

11(31%)

12(34%)

6(17%)

0

Pneumonitis

8(23%)

4(11%)

0

0

Weight loss

3(9%)

1(3%)

0

0

Skin (within the irradiated field)

2(6%)

0

0

0

Fever

1(3%)

3(9%)

0

0

  1. Abbreviations: WBC white blood cell, PLT platelet, HB hemoglobin.